Abstract
Background/objectives
To evaluate the effectiveness of deep learning (DL) algorithms in diagnosing Retinopathy of Prematurity (ROP) cases that requires treatment using fundus images submitted to the ROP clinic as part of a telemedicine consultation system.
Subjects/methods
This retrospective cross-sectional study analysed 1700 RetCam fundus images from 141 preterm infants screened for ROP at Khatam-Al-Anbia Eye Hospital. The images underwent preprocessing using Contrast Limited Adaptive Histogram Equalisation (CLAHE), Automated Multiscale Retinex (AMSR), and a machine learning-based optimisation approach (ML). Various convolutional neural network (CNN) models such as MobileNet, ResNet-18, ResNet-50, and DenseNet-121, were evaluated for their diagnostic performance utilising accuracy, sensitivity, specificity, and F1-score metrics.
Results
Among the models tested, MobileNet with CLAHE preprocessing achieved the highest accuracy (91.39%) and sensitivity (94.90%), establishing it as the most effective model for ROP detection. DenseNet-121 with CLAHE preprocessing showcased high sensitivity (94.26%) but slightly lower accuracy (90.98%). Additionally, ResNet-50 with AMSR preprocessing also demonstrated high accuracy (90.58%) and sensitivity (91.44%). These findings underscore the feasibility of DL models for real-time ROP screening in telemedicine environments.
Conclusion
MobileNet with CLAHE preprocessing exhibited the highest diagnostic performance in identifying treatment-requiring ROP, positioning it as a promising tool for AI-assisted screening. Further validation in varied clinical settings is necessary to confirm its real-world applicability.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
Data availability
The datasets used during the current study are available from the corresponding author on reasonable request.
References
Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis. 2007;10:133–40.
Hellström A, Smith LE, Dammann O. Retinopathy of prematurity. lancet. 2013;382:1445–57.
Azami M, Jaafari Z, Rahmati S, Farahani AD, Badfar G. Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis. BMC Ophthalmol. 2018;18:1–14.
Gebeşçe A, Uslu H, Keleş E, Yildirim A, Gürler B, Yazgan H, et al. Retinopathy of prematurity: incidence, risk factors, and evaluation of screening criteria. Turkish J Med Sci. 2016;46:315–20.
Ozen Tunay Z, Ustunyurt Z, Idil A. Causes of severe visual impairment in infants and methods of management. Eye. 2021;35:1191–7.
Solebo AL, Teoh L, Rahi J. Epidemiology of blindness in children. Archives Dis Child. 2017;102:853–7.
Jonas DE, Amick HR, Wallace IF, Feltner C, Vander Schaaf EB, Brown CL, et al. Vision screening in children aged 6 months to 5 years: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2017;318:845–58.
Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115:e518–e25.
GarcÃa H, Villasis-Keever MA, Zavala-Vargas G, Bravo-Ortiz JC, Pérez-Méndez A, Escamilla-Núñez A. Global Prevalence and Severity of Retinopathy of Prematurity over the Last Four Decades (1985–2021): A Systematic Review and Meta-Analysis. Archives Med Res. 2024;55:102967.
Hansen ED, Hartnett ME. A review of treatment for retinopathy of prematurity. Expert Rev Ophthalmol. 2019;14:73–87.
Quinn GE, Ying G-s, Daniel E, Hildebrand PL, Ells A, Baumritter A, et al. Validity of a telemedicine system for the evaluation of acute-phase retinopathy of prematurity. JAMA Ophthalmol. 2014;132:1178–84.
Hoffer-Hawlik M, Moran A, Zerihun L, Usseglio J, Cohn J, Gupta R. Telemedicine interventions for hypertension management in low-and middle-income countries: a scoping review. PLoS ONE. 2021;16:e0254222.
Mahmoud K, Jaramillo C, Barteit S. Telemedicine in low-and middle-income countries during the COVID-19 pandemic: a scoping review. Front Public Health. 2022;10:914423.
Lu W, Tong Y, Yu Y, Xing Y, Chen C, Shen Y. Applications of artificial intelligence in ophthalmology: general overview. J Ophthalmol. 2018;2018:5278196.
Zhang J, Liu Y, Mitsuhashi T, Matsuo T. Accuracy of Deep Learning Algorithms for the Diagnosis of Retinopathy of Prematurity by Fundus Images: A Systematic Review and Meta-Analysis. J Ophthalmol. 2021;2021:8883946.
Bai A, Carty C, Dai S. Performance of deep-learning artificial intelligence algorithms in detecting retinopathy of prematurity: A systematic review. Saudi J Ophthalmol. 2022;36:296–307.
Ramanathan A, Athikarisamy SE, Lam GC. Artificial intelligence for the diagnosis of retinopathy of prematurity: a systematic review of current algorithms. Eye. 2023;37:2518–26.
LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436–44.
Coyner AS, Murickan T, Oh MA, Young BK, Ostmo SR, Singh P, et al. Multinational external validation of autonomous retinopathy of prematurity screening. JAMA Ophthalmol. 2024;142:327–35.
Young BK, Cole ED, Shah PK, Ostmo S, Subramaniam P, Venkatapathy N, et al. Efficacy of smartphone-based telescreening for retinopathy of prematurity with and without artificial intelligence in India. JAMA Ophthalmol. 2023;141:582–8.
Nguyen TAL, Raileanu V, Smith B, Griffin A, Shah S. Excellent accuracy of trained neonatal nurses in the detection of referral-warranted retinopathy of prematurity within an established telemedicine screening programme. J Paediatrics Child Health. 2024;60:369–74.
Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Chan RP, Berrocal A, et al. International classification of retinopathy of prematurity. Ophthalmology. 2021;128:e51–e68.
Group ETfRoPC. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Archives Ophthalmol. 2003;121:1684–94.
Klaassen B, Van Beijnum B, Hermens HJ. Usability in telemedicine systems—A literature survey. International J Med Inform. 2016;93:57–69.
Lorenz B, Spasovska K, Elflein H, Schneider N. Wide-field digital imaging based telemedicine for screening for acute retinopathy of prematurity (ROP). Six-year results of a multicentre field study. Graefe’s Arch Clin Exp Ophthalmol. 2009;247:1251–62.
Richter GM, Williams SL, Starren J, Flynn JT, Chiang MF. Telemedicine for retinopathy of prematurity diagnosis: evaluation and challenges. Survey Ophthalmol. 2009;54:671–85.
Brady CJ, D’amico S, Campbell JP. Telemedicine for retinopathy of prematurity. Telemedicine e-Health. 2020;26:556–64.
Campbell JP, Singh P, Redd TK, Brown JM, Shah PK, Subramanian P, et al. Applications of artificial intelligence for retinopathy of prematurity screening. Pediatrics. 2021;147:1–8.
Liu Y, Du Y, Wang X, Zhao X, Zhang S, Yu Z, et al. An Artificial Intelligence System for Screening and Recommending the Treatment Modalities for Retinopathy of Prematurity. Asia-Pac J Ophthalmol. 2023;12:468–76.
Attallah O. DIAROP: automated deep learning-based diagnostic tool for retinopathy of prematurity. Diagnostics. 2021;11:2034.
Huang Y-P, Vadloori S, Chu H-C, Kang EY-C, Wu W-C, Kusaka S, et al. Deep learning models for automated diagnosis of retinopathy of prematurity in preterm infants. Electronics. 2020;9:1444.
Huang Y-P, Basanta H, Kang EY-C, Chen K-J, Hwang Y-S, Lai C-C, et al. Automated detection of early-stage ROP using a deep convolutional neural network. British J Ophthalmol. 2021;105:1099–103.
Hu J, Chen Y, Zhong J, Ju R, Yi Z. Automated analysis for retinopathy of prematurity by deep neural networks. IEEE Trans Med Imaging. 2018;38:269–79.
Wang J, Ju R, Chen Y, Zhang L, Hu J, Wu Y, et al. Automated retinopathy of prematurity screening using deep neural networks. EBioMedicine. 2018;35:361–8.
Tong Y, Lu W, Deng Q-q, Chen C, Shen Y. Automated identification of retinopathy of prematurity by image-based deep learning. Eye Vis. 2020;7:1–12.
Redd TK, Campbell JP, Brown JM, Kim SJ, Ostmo S, Chan RVP, et al. Evaluation of a deep learning image assessment system for detecting severe retinopathy of prematurity. British J Ophthalmol. 2019;103:580–4.
Kıran Yenice E, Kara C, Erdaş ÇB. Automated detection of type 1 ROP, type 2 ROP and A-ROP based on deep learning. Eye. 2024;38:2644–8.
Rice L, Wong E, Kolter Z, editors. Overfitting in adversarially robust deep learning. International conference on machine learning; 2020.
Ruamviboonsuk P, Tiwari R, Sayres R, Nganthavee V, Hemarat K, Kongprayoon A, et al. Real-time diabetic retinopathy screening by deep learning in a multisite national screening programme: a prospective interventional cohort study. Lancet Digital Health. 2022;4:e235–e44.
Bora A, Balasubramanian S, Babenko B, Virmani S, Venugopalan S, Mitani A, et al. Predicting the risk of developing diabetic retinopathy using deep learning. Lancet Digital Health. 2021;3:e10–e9.
Funding
The authors would like to acknowledge the financial support of the Vice-Chancellor of Research of Mashhad University of Medical Sciences for this research project (code: 4012360). The funding organisation had no role in the design or conduct of this research.
Author information
Authors and Affiliations
Contributions
NS was designed the work. NS, MRAA, SMH, MMS, MoA, MA, and GZ examined patients images. HRH and NS collected the images. NA and MRH did the CNNs training and tests. HRH and NA analysed the data. All authors were involved in the draughting and review of the manuscript. All authors contributed significantly to this report and agreed to be accountable for all aspects of the work. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Consent for publication
Consent for publication was acquired from patients.
Ethics approval and consent to participate
This study was approved by the Committee of Ethics in Human Research at Mashhad University of Medical Sciences (IR.MUMS.MEDICAL.REC. 1402.158).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shoeibi, N., Ameri, N., Hoseinkhani, M.R. et al. Deep learning algorithms for timely diagnosis of retinopathy of prematurity requiring treatment. Eye 40, 63–70 (2026). https://doi.org/10.1038/s41433-025-04096-3
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-025-04096-3


